{"id":15511,"date":"2016-03-10T15:25:44","date_gmt":"2016-03-10T15:25:44","guid":{"rendered":"https:\/\/rayner.com\/ca\/blog\/rayner-primary-supplementary-iols-now-available-to-surgeons-in-egypt\/"},"modified":"2021-12-03T16:08:27","modified_gmt":"2021-12-03T16:08:27","slug":"rayner-primary-supplementary-iols-now-available-to-surgeons-in-egypt","status":"publish","type":"post","link":"https:\/\/rayner.com\/ca\/rayner-primary-supplementary-iols-now-available-to-surgeons-in-egypt\/","title":{"rendered":"Rayner Primary & Supplementary IOLs now available to surgeons in Egypt"},"content":{"rendered":"


\nRayner\u2019s growth strategy continues as the company announced today that the Egyptian Ministry of Health has approved the following IOLs for sale in Egypt:<\/strong><\/p>\n\n\n\n\n\n\n
\n\"\"<\/td>\n<\/tr>\n
\n\"\"<\/td>\n<\/tr>\n
\n\"\"<\/td>\n<\/tr>\n
\n\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Rayner\u2019s unique system package means that in addition to an IOL, surgeons will also receive a single-use soft-tipped injector and patient card all in one convenient pack \u2013 a strong selling point for Rayner which has contributed to the company\u2019s success world wide.<\/p>\n

Until recently, Rayner\u2019s presence in Egypt was limited to the company\u2019s Ophteis OVD range (more information on the acquisition can be found\u00a0here<\/a>). After a two year IOL registration process to meet the Egyptian Ministry of Health\u2019s strict requirements, Rayner has high hopes in penetrating this market through its exclusive distributor.<\/p>\n

For details on the T-flex<\/em>\u00a0Aspheric Toric IOL approved dioptic range please contact\u00a0iol_enquiries@rayner.com<\/a>.<\/p>\n

To learn more about Rayner\u2019s global product availability, please click\u00a0here<\/a><\/p>\n

-ENDS-<\/strong><\/p>\n

About Rayner Intraocular Lenses Limited.<\/strong>
\nRayner, the pioneering intraocular lens (IOL) manufacturer, has over 65 years of dedication to improving vision and the restoration of sight worldwide. Today, Rayner\u2019s mission remains that of delivering innovative and clinically superior ophthalmic products that consistently respond to the expectations of our global customers and reward the profound trust placed in the company to improve sight and quality of life.<\/p>\n

Rayner has recently moved to a brand new, purpose-built headquarters and state-of-the-art three million per annum capacity lens manufacturing site in Worthing UK. The company markets its IOL portfolio and related products worldwide through a network of distributors in over 70 countries and direct sales teams in the United Kingdom, USA, Germany and Austria.<\/p>\n

For questions or to schedule an interview with a Rayner representative, please contact Rayner:
\niol_enquiries@rayner.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Rayner’s growth strategy continues as the company announced today that the Egyptian Ministry of Health has approved the following IOLs for sale in Egypt:<\/p>\n